Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LATTE trial: Hypertonic sodium lactate after cardiac arrest
2023-506031-15-01Phase 2Authorised
- Sponsor
- Erasmus Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Sodium lactate in anoxic encephalopathy, post-cardiac arrest syndrome (PCAS), coma and 1 more (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Neuron specific enolase peak at 48 hours after ROSC. Planned start Sep 2024; status: authorised.
02
Drugs
Sodium lactate
03
Conditions
anoxic encephalopathypost-cardiac arrest syndrome (PCAS)comacardiac arrest (SCA)
Beyond the preview
Go deeper on 2023-506031-15-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506031-15-01.